How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

13,996 results for

E/M Medical Decision Making

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Multi-criteria decision analysis for the appraisal of medical needs: a pilot study

? REFERENCES 126 KCE Report 272 Multi-criteria decision analysis for the appraisal of medical needs 3 LIST OF FIGURES Figure 1 – Standard reimbursement decision procedure 7 Figure 2 – Early temporary reimbursement process 9 Figure 3 – Criteria and conditions for reimbursement identified by the citizen panel 19 Figure 4 – Steps to be taken in the development of an MCDA framework 20 Figure 5 – MCDA process in decision making 21 Figure 6 – MCDA process applied in Colombia 25 Figure 7 – Patient clusters 34 (...) d’avis en cas d’intervention temporaire pour l’utilisation d’un medicament” CMD College of Medical Directors ETR Early Temporary Reimbursement FAMHP Federal Agency for Medicines and Health Products HTAi Health Technology Assessment International ICER Incremental cost-effectiveness ratio KBF King Baudouin Foundation LUSS Ligue des Usagers des Services de Santé MCDA Multi-criteria decision analysis NIH National Institute of Health PCIG Patient and Citizen Interest Group P.H. Public Health PROMIS

2016 Belgian Health Care Knowledge Centre

42. Shared Decision-Making for Mental Health

decision making in an outpatient psychiatric medication clinic. Psychiatr Serv. 59(6):603-5. 38. Andrews, SB, et al. (2010) Developing web-based online support tools: The dartmouth decision support software. Psychiatr Rehabil J. 34(1):37- 41. 39. Alegria, M, et al. (2008) Evaluation of a patient activation and empowerment intervention in mental health care. Med Care. 46(3):247-56. 40. Cortes, DE, et al. (2009) Patient--provider communication: Understanding the role of patient activation for latinos (...) ) Critical issues for psychiatric medication shared decision making with youth and families. Families in Society: The Journal of Contemporary Social Services. 92(3):310-6. 51. Elwyn, G, et al. (2000) Shared decision making and the concept of equipoise: The competences of involving patients in healthcare choices. Br J Gen Pract. 50(460):892-9. 52. Simmons, M, et al. (2010) Shared decision- making: Bene?ts, barriers and current opportunities for application. Australas Psychiatry. 18(5):394-7

2015 Orygen, The National Centre of Excellence in Youth Mental Health

43. End of Life Decision Making

be made to understand and respect the cultural mores of the patient and her family. Cultural issues may include with whom one communicates within the family, whom the patient looks to for advice and decision making, how the patient feels about the use of pain medications, and how suffering is understood ( ). When a patient lacks the capacity to make health care decisions, the health care provider may be faced with conflicts between surrogate decision makers and cultural expectations. For example (...) Care Planning Since 1991, Medicaid-participating and Medicare-participating health care institutions have been required to inform all adult patients of their rights to make decisions concerning medical care, including the right to formulate an advance directive. The obstetrician–gynecologist is in an ideal position to have ongoing discussions with healthy patients about their values and wishes regarding future care and to encourage them to complete an advance directive for health care by describing

2015 American College of Obstetricians and Gynecologists

44. AUA White Paper on Implementation of Shared Decision Making into Urological Practice

Foundation Website. 2013. http://www.health.org.uk/public/cms/75/76/313/4174/Implementing%20shared%20decision%20making.pdf. 2-3-2015 Wennberg, J. E. Unwarranted variations in healthcare delivery: implications for academic medical centres . BMJ . 2002; 325 : 961 O'Connor, A. M., Llewellyn-Thomas, H. A., and Flood, A. B. Modifying unwarranted variations in health care: shared decision making using patient decision aids . Health Aff (Millwood) . 2004; Suppl Variation : VAR63 Stacey, D., Legare, F., Col, N (...) . F. et al. Decision aids for people facing health treatment or screening decisions . Cochrane Database Syst Rev . 2014 1 : CD001431 Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: The National Academies Press, 2001 Makoul, G. and Clayman, M. L. An integrative model of shared decision making in medical encounters . Patient Educ Couns . 2006; 60 : 301 Charles, C., Gafni, A., and Whelan, T. Shared decision-making in the medical encounter

2015 American Urological Association

45. Bridging the age gap in breast cancer: cluster randomized trial of the effects of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices Full Text available with Trip Pro

Medical School, Falmer, Brighton, UK. 3 College of Health, Wellbeing and Life Sciences, Department of Allied Health Professions, Sheffield Hallam University, Sheffield, UK. 4 Division of Population Medicine, Cardiff University, Cardiff, UK. 5 Department of Health Economics and Decision Science, School for Health and Related Research, ScHARR, University of Sheffield, Sheffield, UK. 6 Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK. 7 Royal (...) increases knowledge of breast cancer treatment options, facilitates shared decision-making, and alters treatment selection.Trial registration numbers: EudraCT 2015-004220-61 (https://eudract.ema.europa.eu/), ISRCTN46099296 (http://www.controlled-trials.com). © The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. Similar articles Collins K, Reed M, Lifford K, Burton M, Edwards A, Ring A, Brain K, Harder H, Robinson T, Cheung KL, Morgan J, Audisio R, Ward S, Richards P

2021 EvidenceUpdates

46. Making Immunization Decisions for School-aged Children: A Rapid Review

studies (two [-] and one [++] found that a range of perceived risks of immunization may influence some parental decisions to delay or avoid immunizations for their children. ? 1 study [-] found concerns around fear of vaccines being contraindicated for existing medical conditions 48 ? 3 studies ([-], [+], [++]) found concerns about combined antigens putting too much stress on a baby's immune system ? 4 studies (three [-], one [+]) found that when parents are making the decision to immunize (...) Making Immunization Decisions for School-aged Children: A Rapid Review 2 Making immunization decisions for school-aged children: A Rapid Review Anita Tsang-Sit, Analyst, Research and Policy Paulette Whyte, Supervisor Loretta Rowan, Manager August 25, 2014 i Table of Contents Key Messages 2 Executive Summary 3 1 Issue 6 2 Context 7 3 Conceptual Framework 9 4 Literature Review Question 10 5 Literature Search 10 6 Relevance Assessment 11 7 Results of the Search 12 8 Critical Appraisal 12 9

2014 Peel Health Library

47. “What matters most to you?” How decision aids help patients make better choices

a choice about antibiotic treatment for a child with an ear infection. It’s great to see projects under way such as Portsmouth Hospital NHS Trust’s ‘My Birthplace’ project to develop an app to help women decide where to have their baby. The voices clamoring for patients to be at the centre of their care, at the centre of evidence and at the centre of decision-making are growing louder and can be heard in the current debate about ‘Real Evidence-based Medicine’ (check out #RealEBM on Twitter). Dr Richard (...) and that research is needed on interventions that support shared decision-making between women considering mode of birth in a pregnancy after a caesarean birth and their care providers. (1) Horey D, Kealy M, Davey MA, Small R, Crowther CA. Interventions for supporting pregnant women’s decision-making about mode of birth after a caesarean. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD010041. DOI: 10.1002/14651858.CD010041.pub2. (2) Elwyn G, Frosch D, Volandes A, Edwards A, Montori V

2014 Evidently Cochrane

48. Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis Full Text available with Trip Pro

positive/her2 negative breast cancer. Oncologist 23(3):297–305 45. Martinez Del Prado P, Alvarez-Lopez I, Dominguez-Fernandez S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martinez A, Mar J (2018) Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals. Clinicoecon Outcomes Res 10:189–199. 46. Panousis D (...) of recurrence – a systematic review and meta-analysis Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis , , , , , , , , & , , volume 76 , pages 1199 – 1211 ( 2020 ) 587 Accesses Abstract Purpose To assess the evidence for decision making, at the health care and the patient levels, regarding the use of gene expression assays to inform chemotherapy decisions in breast cancer patients

2020 European journal of clinical pharmacology

49. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Published in the March 2015 issue of Genetics in M Full Text available with Trip Pro

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Published in the March 2015 issue of Genetics in M Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Genetics in Medicine Thank you (...) for Molecular Pathology , , , , , , , , , , , , , , , & ; on behalf of the ACMG Laboratory Quality Assurance Committee Genetics in Medicine volume 17 , pages 405 – 423 (2015) | Subjects Abstract Disclaimer: These ACMG Standards and Guidelines were developed primarily as an educational resource for clinical laboratory geneticists to help them provide quality clinical laboratory services. Adherence to these standards and guidelines is voluntary and does not necessarily assure a successful medical outcome

2015 Association for Molecular Pathology

50. Protocol for a Prospective (P) study to develop a model to stratify the risk (RI) of medication (M) related harm in hospitalized elderly (E) patients in the UK (The PRIME study). Full Text available with Trip Pro

Protocol for a Prospective (P) study to develop a model to stratify the risk (RI) of medication (M) related harm in hospitalized elderly (E) patients in the UK (The PRIME study). Medication related harm (MRH) is a common cause of morbidity and hospital admission in the elderly, and has significant cost implications for both primary and secondary healthcare resources. The development of risk prediction models has become an increasingly common phenomenon in medicine and can be useful to guide (...) objective clinical decision making, resource allocation and intervention. There are no risk prediction models that are widely used in clinical practice to identify elderly patients at high risk of MRH following hospital discharge. The aim of this study is to develop a risk prediction model (RPM) to identify elderly patients at high risk of MRH upon discharge from hospital, and to compare this with routine clinical judgment.This is a multi-centre, prospective observational study following a cohort

2016 BMC Geriatrics

51. How Returning Aggregate Research Results Impacts Interest in Research Engagement and Planned Actions Relevant to Health Care Decision Making: Cohort Study. Full Text available with Trip Pro

a "virtuous cycle" of research engagement, especially where ARRs are experienced favorably and affect plans to share and discuss ARRs in support of a child's chronic disease care and treatment. Reactions to ARRs vary with education level, underscoring the need for attention to equity for this model.©Elissa R Weitzman, Kara M Magane, Lauren E Wisk. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 21.12.2018. (...) How Returning Aggregate Research Results Impacts Interest in Research Engagement and Planned Actions Relevant to Health Care Decision Making: Cohort Study. Collection of patient-reported outcomes measures (PROs) may augment clinical data and inform health research, improving care, yet approaches to sustaining interest among patient cohorts in research participation are needed. One approach may involve returning aggregate research results (ARRs), which may help patients contextualize personal

2018 Journal of medical Internet research

52. Why New Drugs, Treatments, and Medical Devices Still Needs to be Tested Clinically Before Making it Available in the Market? A Systematic Review Full Text available with Trip Pro

Why New Drugs, Treatments, and Medical Devices Still Needs to be Tested Clinically Before Making it Available in the Market? A Systematic Review Why New Drugs, Treatments, and Medical Devices Still Needs To Be Tested Clinically Before Making It Available in the Market? - Why New Drugs, Treatments, and Medical Devices Still Needs To Be Tested Clinically Before Making It Available in the Market? - Open Access Pub Toggle navigation Menu Toggle navigation Menu Journal of Neurological Research (...) and Therapy ISSN: 2470-5020 Current Issue Volume No: 3 Issue No: 1 share this page Review Article | Open Access Available online freely | Peer Reviewed Why New Drugs, Treatments, and Medical Devices Still Needs to be Tested Clinically Before Making it Available in the Market? Naiya Patel 1 1 Graduate Research Assistant, Department of Public Health, Long Island University, Brooklyn, New York, United States, PMBA candidate, MPH, BDS. Abstract Objective Testing a new drug, treatment, and medical device

2019 Journal of neurological research and therapy

53. Factors Informing Clinical Decisions about Ventilator Use during Ventilator Shortages in an Infectious Disease Pandemic

Factors Informing Clinical Decisions about Ventilator Use during Ventilator Shortages in an Infectious Disease Pandemic CLINICAL EVIDENCE ASSESSMENT © April 15, 2020 ECRI Factors Informing Clinical Decisions about Ventilator Use during Ventilator Shortages in an Infectious Disease Pandemic During infectious disease pandemics, hospitals can become overwhelmed if many patients require life-saving measures. Ventilator shortages are common, and clinicians must make critical decisions regarding (...) their use (i.e., who gets one, when to terminate care). Factors that may inform decision making during ventilator shortages include patient age, presence of comorbidities, expected survival, and existence of advanced directives. In this report, we examine the effectiveness of triage systems for identifying disease severity and mortality risk to inform decisions on scarce resource allocation during pandemics. The Evidence Bar™ Evidence raises concerns We identified 14 guidelines, 4 triage frameworks

2020 Covid-19 Ad hoc papers

54. Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence

of the investigators have any affiliations or financial involvement that conflicts with the material presented in this report. The information in this report is intended to help healthcare decision makers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of healthcare services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision (...) for acknowledgment: This work was based on an evidence report, Improving the Utility of Uncertain Findings in Systematic Reviews for Healthcare Decisionmakers, by the Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality (AHRQ). Suggested citation: Murad MH, Chang SM, Fiordalisi C, Lin JS, Wilt TJ, Tsou A, Leas B, Siddique S, Zullo A, Balk E, Rutter CM, Robinson K, Coleman C, Costa O, Stoeger E, Arkhipova-Jenkins I, Helfand M, Viswanathan M. Improving the Utility of Evidence

2021 Effective Health Care Program (AHRQ)

55. HIV Prevention: Clinical Decision Support System to Increase HIV Screening

4:10.4172/2155-6113.S4-006. Burrell CN, Sharon MJ, Davis SM, Wojcik EM, Martin IB. Implementation of a collaborative HIV and hepatitis C screening program in Appalachian urgent care settings. Western Journal of Emergency Medicine 2018;19(6):1057. Chadwick DR, Hall C, Rae C, Rayment MI, Branch M, et al. A feasibility study for a clinical decision support system prompting HIV testing. HIV Medicine 2017;18(6):435-9. Clarke E, Bhatt S, Patel R, Samraj S. Audit of the effect of electronic patient (...) program in two Federally Qualified Health Centers in the southern United States. Public Health Reports 2016;131(Supp 1):21-9. Federman DG, Kravetz JD, Vasquez LS, Campbell SM. Improving human immunodeficiency virus testing rates with an electronic clinical reminder. American Journal of Medicine 2012;125(3):240-2. Felsen UR, Cunningham CO, Heo M, et al. An expanded HIV testing strategy leveraging the electronic medical record uncovers undiagnosed infection among hospitalized patients. Journal

2020 Community Preventive Services Task Force

56. Shared Decision-Making in Intensive Care Units. Executive Summary of the American College of Critical Care Medicine and American Thoracic Society Policy Statement Full Text available with Trip Pro

.201602-0269ED Kon Alexander A AA 1 Naval Medical Center San Diego San Diego, California. 2 University of California San Diego San Diego, California. Davidson Judy E JE 3 University of California Health System San Diego, California. Morrison Wynne W 4 Children's Hospital of Philadelphia Philadelphia, Pennsylvania. Danis Marion M 5 National Institutes of Health Bethesda, Maryland and. White Douglas B DB 6 University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania. eng Journal Article Practice (...) Shared Decision-Making in Intensive Care Units. Executive Summary of the American College of Critical Care Medicine and American Thoracic Society Policy Statement 27097019 2017 12 26 2018 11 13 1535-4970 193 12 2016 06 15 American journal of respiratory and critical care medicine Am. J. Respir. Crit. Care Med. Shared Decision-Making in Intensive Care Units. Executive Summary of the American College of Critical Care Medicine and American Thoracic Society Policy Statement. 1334-6 10.1164/rccm

2016 American Journal of Respiratory and Critical Care Medicine

57. Choosing Wisely Canada recommendation - Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in th

Vitamin D levels in patients with significant renal or metabolic disease. 1 2 3 Family Medicine Thirteen Things Physicians and Patients Should Question by College of Family Physicians of Canada Last updated: January 2018 4 5 6Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in this age group. If, after this careful assessment and discussion (...) : 22450938. Canadian Association of Radiologists. 2012 CAR diagnostic imaging referral guidelines. Section E: cardiovascular [Internet]. 2012 [cited 2017 May 9]. Canadian Association of Radiologists. Medical imaging primer with a focus on x-ray usage and safety [Internet]. 2013 [cited 2017 May 9]. Tigges S, et al. Routine chest radiography in a primary care setting. Radiology. 2004 Nov;233(2):575-8. PMID: 15516621. U.S. Preventive Services Task Force (USPSTF). Screening for coronary heart disease

2019 CPG Infobase

58. Options for national testing and surveillance for hepatitis E virus in the EU/EEA

1. Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017 Nov 16;3:17086. 2. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016 Sep 10;388(10049):1081-1088. 3. European Commission. Commission implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases (...) with the proposal to include the monitoring of chronic infections as a primary objective and suggested that the incidence of chronic infections could be a secondary objective if the surveillance system implemented allows for it. Otherwise, the chronic infections issue may be addressed through specific studies (on risk factors or immunopathogenesis). iv According to structure and decision by each country. TECHNICAL REPORT Options for national testing and surveillance for hepatitis E virus in the EU/EEA

2019 European Centre for Disease Prevention and Control - Technical Guidance

59. E/M Medical Decision Making

E/M Medical Decision Making E/M Medical Decision Making Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 E/M Medical Decision Making E (...) /M Medical Decision Making Aka: E/M Medical Decision Making , E/M Straightforward Medical Decision , E/M Low Complexity Medical Decision , E/M Moderate Complexity Medical Decision , E/M High Complexity Medical Decision II. Decision Making Type: Straightforward Criteria Minimal number of diagnoses or management options Minimal or no data to be reviewed Minimal risk of complications, morbidity, mortality Related Codes III. Decision Making Type: Low Complexity Criteria Limited number of diagnoses

2015 FP Notebook

60. Clinical Decision-Making and Best Practices for Potential Organ and Tissue Donors: Guidelines

Management to Optimize Donor Organ Potential. CMAJ [Internet]. 2006 Mar 14 [cited 2012 Apr 5];174(6):S13-S32. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402396 PubMed: PM16534070 PREPARED BY: Canadian Agency for Drugs and Technologies in Health Tel: 1-866-898-8439 www.cadth.ca Clinical Decision-Making and Best Practices for Potential Organ and Tissue Donors 3 APPENDIX – FURTHER INFORMATION: Practice Guidelines and Recommendations 6. Kucewicz E, Wojarski J, Zeglen S, Saucha W (...) ://www.organsandtissues.ca/s/wp-content/uploads/2011/11/Donor- Clinical Decision-Making and Best Practices for Potential Organ and Tissue Donors 4 Organ-Mgmt-Lit-Review.pdf Prepared for the forum: Medical management to optimize donor organ potential. February 23-25, 2004. 15. Van Raemdonck DE, Rega FR, Neyrinck AP, Jannis N, Verleden GM, Lerut TE. Non- heart-beating donors. Semin Thorac Cardiovasc Surg. 2004;16(4):309-21. PubMed: PM15635535 Additional References 16. Browne A. The ethics of organ donation after

2012 Canadian Agency for Drugs and Technologies in Health - Rapid Review

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>